Appointment Ceremony for the co-editors of iLIVER Held Successfully
Group photo of all attendees
On April 27th, 2024, “the 2024 Liver Cancer Summit Forum and Yttrium-90 International Exchange Forum" was held successfully in Beijing, hosted by Tsinghua University, organized by Tsinghua University School of Medicine, Beijing Tsinghua Changgung Hospital, and the Professional Committee of Hepatobiliary Pancreatic Surgery of the Chinese Research Hospital Association, and jointly organized by the Editorial Board of the Chinese Journal of Digestive Surgery and the Editorial Board of iLIVER. The forum was attended by experts in the field of liver cancer from the Chinese Medical Association(CMA), the Chinese Research Hospital Association(CRH), Tsinghua University(TU) and also renowned scholars from seven countries/regions to discuss innovative diagnostics and treatment of liver cancer and internal precision radiotherapy with yttrium-90, share the latest developments, advanced clinical treatment, and innovative methods and research and their application.
The appointment ceremony (from left to right): Chairman Zong Junfeng, Academician CHEN Chao-Long, Professor Pierre-Alain Clavien, Academician DONG Jiahong
The appointment ceremony for the co-editors of iLIVER Magazine was also held during the forum. Professor DONG Jiahong, the editor-in-chief of iLIVER, and ZONG Junfeng, Chairman of Tsinghua University Press, handed over the editor certificates to Academician CHEN Chao-Long and Professor Pierre-Alain Clavien.
CHEN Chao-Long
Co-Editor-in-Chief of iLIVER
Professor CHEN Chao-Long is a pioneering figure in liver transplantation in Taiwan Province, P.R. China and Asia. In 1984, Professor Chen performed the first successful liver transplant surgery in Asia and was a driving force in Taiwan's adoption of brain death criteria, leading to the legislation of Asia's first brain death organ transplantation in 1987. This legislation preceded those of Japan, South Korea, and Hong Kong SAR, P.R. China by 10 to 12 years and led to the vigorous development of organ transplantation in Taiwan Province, P.R. China.
Over the past three decades, Professor Chen has set numerous records in liver transplantation in Taiwan Province, P.R. China, Asia, and globally, maintaining one of the highest survival rates in living donor liver transplantation. He completed Taiwan's first pediatric living donor liver transplant in 1994, the world's first bloodless living donor liver transplant in 1997, Asia's first split liver transplant operation, where one liver was transplanted into two recipients in the same surgery, also in 1997, Taiwan's first adult living donor liver transplant in 1999, the first living donor dual liver transplant in the Chinese population in 2002, and Taiwan's first monosegment liver transplant in 2013. By 2016, he had accomplished 1500 liver transplant surgeries. In 2006, Professor Chen published in the American Journal of Transplantation on the treatment of bile duct obstruction through living donor liver transplantation, achieving a five-year survival rate of 98%. In 2008, he published in Transplantation on living donor liver transplantation for liver cancer, achieving a five-year survival rate of 90%, the highest reported in literature.
Professor Chen has continuously broken records and improved standards over his more than 30-year career, solidifying his international academic standing in liver transplantation. He has innovated and improved techniques and strategies in living donor liver transplantation to achieve world-leading results, with over 400 SCI-cited academic papers published. He serves as associate editor of the American Journal of Transplantation and on the editorial boards of Annals of Surgery, Transplantation, Liver Transplantation, iLIVER, and other world-class academic journals. He has been invited to speak at over 300 international and overseas medical conferences and has conducted related basic research, driving the development of related medical technologies. He has trained over 300 liver transplant physicians domestically and internationally, making outstanding contributions to the cause of public health and improvement of medical standards.
Professor Chen was selected as the first distinguished alumnus of Kaohsiung Medical University in 1992, elected as an Academician of the Chinese Academy of Engineering in 2007, awarded the Taiwan Medical Dedication Award for Special Medical Contribution in 2015, and received the first International Medical Model Award in 2016. With his philosophy of open medicine, Professor Chen actively assists domestic and international university hospitals in developing liver transplantation programs and is dedicated to international medical aid. He was awarded the Friendship Medal of Diplomacy in Taiwan in 2015, the Commander's Medal of Francisco Morazan by the Central American Parliament, and has served as a consultant on Asia-Pacific policy for the RAND Corporation since 2016.
Pierre-Alain Clavien
Co-Editor-in-Chief of iLIVER
Professor Pierre A. Clavien is a world-leading expert in hepatobiliary and pancreatic surgery and liver transplantation, with over 1000 published papers and numerous groundbreaking research achievements.
The Clavien complication classification system, widely used in the field of surgery, continues to guide surgeons globally in the management of postoperative complications and quality control. In the field of transplantation, Professor Clavien's team preserved a human liver through ex vivo perfusion, implanted it into a recipient three days later, and achieved successful outcomes, causing a significant academic stir. His laboratory discovered serotonin as a key mediator of liver regeneration and the pathogenesis of cancer (Science 2008). Dr. Clavien also developed a simple and widely used system to evaluate postoperative complications, which bears his name.
Professor Clavien has served as president of the European Surgical Association (ESA), the European Hepatobiliary Association (E-AHPBA), and the Swiss Transplantation Society. He currently serves on the editorial boards or as associate editor of several prestigious international journals, including Gastroenterology, Hepatology, Surgery, the American Journal of Transplantation, and the Journal of Hepatology, as well as iLIVER. He was appointed Associate Editor of Annals of Surgery to cover liver topics and Editor for ESA articles.
For his outstanding contributions, Professor Clavien has received numerous competitive grants and awards, including one of Switzerland's most prestigious scientific research awards, the Otto Naegeli Award, and the 2012 UEGW (European Union of Gastroenterology) award for his research in partial liver transplantation. In 2014, he was awarded an honorary fellowship by the American College of Surgeons (ACS), and in 2016, he received an honorary fellowship from the American Surgical Association (ASA).